PMID- 31587051 OWN - NLM STAT- MEDLINE DCOM- 20200924 LR - 20221207 IS - 1945-7197 (Electronic) IS - 0021-972X (Linking) VI - 105 IP - 2 DP - 2020 Feb 1 TI - Bone Histomorphometry in Young Patients With Type 2 Diabetes is Affected by Disease Control and Chronic Complications. LID - dgz070 [pii] LID - 10.1210/clinem/dgz070 [doi] AB - CONTEXT: Type 2 diabetes mellitus (T2DM) is associated with an increased risk of fractures. No study has evaluated the correlation of bone histomorphometry (BH) parameters with glycemic control and presence of chronic complications (CCs) in premenopausal women with T2DM. OBJECTIVES: To evaluate BH and correlate them with the degree of glycemic control and presence of CCs. DESIGN, SETTINGS, AND PATIENTS: This was a cross-sectional study conducted at a tertiary medical center. Twenty-six premenopausal women with T2DM were divided into groups with glycated hemoglobin HbA1c < 7% (good control, GC; n = 10) and HbA1c > 7% (poor control, PC; n = 16), and further subdivided into groups with (n = 9) and without (n = 17) CCs. BH parameters (bone volume [bone volume per total volume, BV/TV], trabecular thickness [Tb.Th], trabecular number [Tb.N], trabecular separation [Tb.Sp], osteoid thickness [O.Th], osteoid surface [osteoid surface per bone surface, OS/BS]), mineralizing surface [MS/BS], bone formation rate [BFR]), mineral apposition rate [MAR]) as well as serum pentosidine (PEN) and insulin-like growth factor (IGF)-1 were measured. The BH data were compared among the groups and with a BH control group (control group, CG, n = 15) matched by age, sex, and race. RESULTS: BV/TV was increased in GC (P < .001) and PC (P = .05) groups and O.th (P = .03) was smaller in the PC group than in the CG. A comparison of the groups with and without CCs with the CG showed in the group with CCs, O.Th was smaller(P = .01) and BV/TV similar to the CG (P = .11). HbA1c correlated negatively with O.Th (P = .02) and OS/BS (P = .01). There was no correlation of BH to PEN and IGF-1. CONCLUSION: BH in premenopausal patients with T2DM is affected by disease control and chronic complications. CI - (c) Endocrine Society 2019. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. FAU - Andrade, Vicente F C AU - Andrade VFC AD - Endocrine Division (SEMPR), Department of Internal Medicine, Federal University of Parana, Curitiba, Brazil. FAU - Chula, Domingos C AU - Chula DC AD - Nephrology Unit, Clinics Hospital of Federal University of Parana, Curitiba, Brazil. FAU - Sabbag, Fabio P AU - Sabbag FP AD - Ophthalmologist, retinal and vitreo specialist at the Clinic Center of Vision, Medical School of Ribeirao Preto, Sao Paulo University, Curitiba, Sao Paulo, Brazil. FAU - Cavalheiro, Daniel D da S AU - Cavalheiro DDDS AD - Radiology Clinic, Advanced Diagnostic Imaging (DAPI), Curitiba, Brazil. FAU - Bavia, Lorena AU - Bavia L AD - Laboratory of Molecular Immunopathology, Department of Medical Pathology, Clinics Hospital of Federal do Parana University, Brazil. FAU - Ambrosio, Altair Rogerio AU - Ambrosio AR AD - Laboratory of Molecular Immunopathology, Department of Medical Pathology, Clinics Hospital of Federal do Parana University, Brazil. FAU - da Costa, Cleber Rafael V AU - da Costa CRV AD - Laboratory PRO, Section of bone histomorphometry, Fundacao Pro-Renal, Curitiba, Brazil. FAU - Dos Reis, Luciene M AU - Dos Reis LM AD - LIM 16 - Laboratory of Renal Physiopathology, Clinics Hospital (HCFMUSP), School of Medicine, University of Sao Paulo, Sao Paulo, Brazil. FAU - Borba, Victoria Z C AU - Borba VZC AD - Endocrine Division (SEMPR), Department of Internal Medicine, Federal University of Parana, Curitiba, Brazil. FAU - Moreira, Carolina Aguiar AU - Moreira CA AD - Endocrine Division (SEMPR), Department of Internal Medicine, Federal University of Parana, Curitiba, Brazil. AD - Laboratory PRO, Section of bone histomorphometry, Fundacao Pro-Renal, Curitiba, Brazil. LA - eng PT - Journal Article PT - Observational Study PL - United States TA - J Clin Endocrinol Metab JT - The Journal of clinical endocrinology and metabolism JID - 0375362 RN - 0 (Blood Glucose) RN - 0 (Glycated Hemoglobin A) RN - 0 (IGF1 protein, human) RN - 0 (hemoglobin A1c protein, human) RN - 67763-96-6 (Insulin-Like Growth Factor I) RN - 94ZLA3W45F (Arginine) RN - BJ4I2X2CQJ (pentosidine) RN - K3Z4F929H6 (Lysine) SB - IM MH - Adult MH - Arginine/analogs & derivatives/blood MH - Blood Glucose/analysis MH - *Bone Development MH - Bone Diseases/*etiology MH - Cancellous Bone/physiopathology MH - Chronic Disease MH - Cross-Sectional Studies MH - Diabetes Mellitus, Type 2/blood/complications/*physiopathology MH - Female MH - Glycated Hemoglobin/analysis MH - Humans MH - Insulin-Like Growth Factor I/analysis MH - Lysine/analogs & derivatives/blood MH - Male EDAT- 2019/10/07 06:00 MHDA- 2020/09/25 06:00 CRDT- 2019/10/07 06:00 PHST- 2019/05/21 00:00 [received] PHST- 2019/10/03 00:00 [accepted] PHST- 2019/10/07 06:00 [pubmed] PHST- 2020/09/25 06:00 [medline] PHST- 2019/10/07 06:00 [entrez] AID - 5582037 [pii] AID - 10.1210/clinem/dgz070 [doi] PST - ppublish SO - J Clin Endocrinol Metab. 2020 Feb 1;105(2):dgz070. doi: 10.1210/clinem/dgz070.